Gorevic Jason N's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Nov 4, 2021
- Accession no.
- 0001179110-21-009877
- Filed
- Nov 4, 2021
- Trade date
- Nov 2, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.51M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorevic Jason NCIK 0001208500 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of transactions ranging from $150.00 to $150.99, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 3 to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of transactions ranging from $151.15 to $151.44, inclusive.
Referenced by the price of 1 transaction in Table I.